EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control

Ayan K Ghosh, Yu-Pin Su, Michael Forman, Robert F Keyes, Brian C Smith, Xin Hu, Marc Ferrer, Ravit Arav-Boger iD

Journal of Virology · 2023

DOI: 10.1128/jvi.00160-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Ayan K Ghosh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections, Virus Replication. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusCytomegalovirus InfectionsVirus ReplicationAntiviral AgentsTranscription, GeneticPhosphorylationAntioxidant Response ElementsCell LineHumansSulfonamidesKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Sequestosome-1 ProteinRNA-Binding Proteins

Stichwörter der Autor:innen

ARP101SQSTM1/p62antioxidant response elementhuman cytomegalovirusnoncanonical Keap1-Nrf2 pathwayp62-Keap1-Nrf2

Substanzen

Antiviral AgentsARP101 compoundSulfonamidesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2SQSTM1 protein, humanSequestosome-1 ProteinP62 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Pediatrics, Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Biochemistry, Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, Maryland, USA.

ORCID-Profile: Ravit Arav-Boger

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of General Medical Sciences
  • Children's Wisconsin Research Institute

Zitieren

APA

Ghosh, A. K., Su, Y. P., Forman, M., Keyes, R. F., Smith, B. C., Hu, X., Ferrer, M., & Arav-Boger, R. (2023). Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. Journal of Virology. https://doi.org/10.1128/jvi.00160-23

Vancouver

Ghosh AK, Su YP, Forman M, Keyes RF, Smith BC, Hu X, et al. Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. Journal of Virology. 2023. doi:10.1128/jvi.00160-23

BibTeX
@article{Ghosh2023,
  author = {Ghosh, Ayan K and Su, Yu-Pin and Forman, Michael and Keyes, Robert F and Smith, Brian C and Hu, Xin and Ferrer, Marc and Arav-Boger, Ravit},
  title = {Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control},
  journal = {Journal of Virology},
  year = {2023},
  doi = {10.1128/jvi.00160-23}
}
Kostenlos starten →